One study reported that Galectin-3 can bind to MICA, which is a ligand to the activating NK cell receptor NKG2D, and that this Galectin-3-MICA complex caused disturbed interaction with NKG2D and thereby reduced NK cell killing of bladder cancer cells (85). The gene discussed is KLRK1; the disease is urinary bladder carcinoma.